ArticleACS chemical neuroscience2025

Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination.

Muge Didem Orhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.